Jay Mulaney

Double-Masked Controlled Trial of H-1337 as a Treatment for Glaucoma and Ocular Hypertension

Lee Shettle, Jay Mulaney, Robert D. Williams, Jennifer N. Beck et autres

PURPOSE: Extend Phase 2A study to evaluate additional concentrations of H-1337 and dosing frequencies, and to compare them with a positive control. DESIGN: Phase 2B, randomized, double-masked, active-controlled, dose-response study of 28 days of four treatments: H-1337 0.6% b.i.d., 1.0% b.i.d., or …

us (code pays fourni par la source)

A Randomized, Controlled Comparison of NCX 470, a Nitric Oxide-Donating Bimatoprost, and Latanoprost in Subjects with Open-Angle Glaucoma or Ocular Hypertension: The MONT BLANC Study

Robert D. Fechtner, Steven L. Mansberger, James Branch, Jay Mulaney et autres

us (code pays fourni par la source)

Netarsudil/Latanoprost Fixed-Dose Combination for Elevated Intraocular Pressure: Three-Month Data from a Randomized Phase 3 Trial

Sanjay Asrani, Alan Lee Robin, Janet B. Serle, Richard Alan Lewis et autres

PURPOSE: To compare the ocular hypotensive efficacy and safety of a fixed-dose combination (FDC) of the Rho kinase inhibitor netarsudil and latanoprost vs monotherapy with netarsudil or latanoprost. DESIGN: Three-month primary endpoint analysis of a randomized, double-masked, phase 3 clinical trial. METHODS: …

us (code pays fourni par la source)

Comparison of Daytime Efficacy and Safety of Dorzolamide/Timolol Maleate Fixed Combination versus Latanoprost

Jay Mulaney, Sriram Sonty, Akil Ahmad, Jeanette A. Stewart et autres

PURPOSE: To compare the 12-hour efficacy and safety of dorzolamide/timolol fixed combination (DTFC) dosed twice daily versus latanoprost dosed every evening following a timolol run-in in primary open-angle glaucoma patients. METHODS: Following a 6-week timolol run-in patients were randomized to either DTFC …

us (code pays fourni par la source)